Terbutaline is approved to prevent and treat bronchospasm (narrowing of airways) associated with asthma, bronchitis, and emphysema.
FDA Drug Safety Podcast for Healthcare Professionals: New warnings against use of terbutaline to treat preterm labor[ARCHIVED] FDA Drug Safety Communication: New warnings against use of terbutaline to treat preterm labor[ARCHIVED]
FDA Response to Citizen Petition on Terbutaline(PDF - 151KB)
FDA warns against certain uses of asthma drug terbutaline for preterm labor[ARCHIVED]
Press Release - 2/17/2011